Brokerages Set Veeva Systems Inc . ( NYSE : VEEV ) Target Price at $229 . 96

Veeva Systems Inc., a cloud-based software provider for the life sciences industry, has a consensus rating of Moderate Buy from 23 research firms. The average twelve-month price objective is $229.96. Analysts ratings vary, with 15 recommending a buy, seven holding, and one suggesting a sell. Recent price targets have been raised by Piper Sandler and Guggenheim, while Truist Financial and Raymond James have given hold and outperform ratings, respectively. The company s market capitalization stands at $35.23 billion, with a price-to-earnings ratio of 64.29 and a beta of 0.81. Its 50-day and 200-day simple moving averages are $196.14 and $201.88, respectively. The stock s 52-week low and high are $162.72 and $236.90. Insider activity includes SVP Jonathan Faddis selling 2,353 shares at an average price of $200.00, now owning 9,035 shares valued at approximately $1,807,000. Corporate insiders own 10.50% of the stock. Institutional trading shows Facet Wealth Inc. increasing its holdings by 3.2%, Clearbridge Investments LLC by 0.4%, Western Pacific Wealth Management LP by 23.3%, OV Management LLC by 1.0%, and Quadrant Capital Group LLC by 14.7%. Hedge funds and other institutional investors hold 88.20% of the company s stock. Veeva Systems offers various software solutions for pharmaceutical and biotechnology companies, including CRM, content and digital asset management, medical content, analytics platforms, customer reference data, and patient data. MarketBeat Ratings provides a daily summary of news and analyst ratings for Veeva Systems and related companies.

Source: modernreaders.com
Published on 2024-09-15

Biden sanctions Iran aeroterror fleet , but will he enforce his own sanctions ? »

Open Data

Related news